Redwood Pharma to present at AKTIEPORTFÖLJEN LIVE SVERIGE in Stockholm on 11[th] of Oct. 2022 at 14:45

Redwood Pharma will participate in the Aktieportföljen Live in Stockholm. CEO Martin Vidaeus will update the market about its products in development including the medical device RP501 which is nearing market clearance/approval.

The presentation including a question and answers period will be live-streamed through the Aktieportföljen Live website: https://aktieporfoljen.se

The presentation will be held in English.

See you on October 11 at 14:45!